2941.10.20 | 00 | Penicillin G salts | kg | Free | | 15.4¢/kg + 49% |
2941.10.30 | 00 | Other: | | | | |
2941.10.50 | 00 | Other | kg | Free | | 15.4¢/kg + 56.5% |
2941.20 | | Streptomycins and their derivatives; salts thereof: | | | | |
2941.20.10 | 00 | Dihydrostreptomycin and its derivatives; salts thereof | g | 3.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 25% |
2941.20.50 | 00 | Other | g | Free | | 25% |
2941.30.00 | 00 | Tetracyclines and their derivatives; salts thereof | g | Free | | 25% |
2941.40.00 | 00 | Chloramphenicol and its derivatives; salts thereof | kg | Free | | 15.4¢/kg + 45% |
2941.50.00 | 00 | Erythromycin and its derivatives; salts thereof | g | Free | | 25% |
2941.90 | | Other: | | | | |
2941.90.10 | | Natural | | Free | | 10% |
2941.90.10 | 10 | Aminoglycoside antibiotics | kg | | | |
2941.90.10 | 50 | Other | kg | | | |
2941.90.30 | 00 | Other: | | | | |
2941.90.30 | 00 | Aromatic or modified aromatic | kg | Free | | 15.4¢/kg + 45% |
2941.90.50 | 00 | Other | kg | Free | | 25% |
2942.00 | | Other organic compounds: | | | | |
2942.00.03 | 00 | Aromatic or modified aromatic: | | | | |
2942.00.03 | 00 | [2,2'-Thiobis(4-(1,1,3,3-tetramethyl-n-butyl)- phenolato)(2,1)]-O,O',S-(1-butanamine), nickel II | kg | Free | | 15.4¢/kg + 46.5% |
2942.00.05 | 00 | Other: | | | | |
2942.00.10 | 00 | Other: | | | | |
2942.00.10 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 2.9% (SG) | 15.4¢/kg + 46.5% |
2942.00.35 | 00 | Other | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 3.1% (SG) | 15.4¢/kg + 46.5% |
2942.00.50 | 00 | Other | kg | 3.7% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 25% |
3001 | | Glands and other organs for organotherapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organotherapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included: | | | | |